OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abatacept in the treatment of localized scleroderma: A pediatric case series and systematic literature review
Ioannis Kalampokis, Belina Y. Yi, Aimee C. Smidt
Seminars in Arthritis and Rheumatism (2020) Vol. 50, Iss. 4, pp. 645-656
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes
Robert Knobler, Marija Geroldinger‐Simić, Alexander Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 7, pp. 1251-1280
Closed Access | Times Cited: 6

Upcoming treatments for morphea
Dan Wenzel, Nazgol‐Sadat Haddadi, Khashayar Afshari, et al.
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 4, pp. 1101-1145
Open Access | Times Cited: 28

Morphoea and Allied Scarring and Sclerosing Inflammatory Dermatoses
Catherine H. Orteu
(2024), pp. 1-52
Closed Access | Times Cited: 4

A review on applications of abatacept in systemic rheumatic diseases
Min Liu, Yikai Yu, Shaoxian Hu
International Immunopharmacology (2021) Vol. 96, pp. 107612-107612
Closed Access | Times Cited: 25

Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: a scoping review
Seher Şener, Ezgi Deniz Batu
Seminars in Arthritis and Rheumatism (2025), pp. 152634-152634
Closed Access

New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review
Chiara Sassetti, Claudia Borrelli, Martha Mazuy, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 643-643
Open Access

Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma
Suzanne C. Li, Kathryn S. Torok, Sarah S Ishaq, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 8, pp. 3817-3825
Closed Access | Times Cited: 24

Juvenile Localized Scleroderma
Natalia Vasquez‐Canizares, Suzanne C. Li
Rheumatic Disease Clinics of North America (2021) Vol. 47, Iss. 4, pp. 737-755
Closed Access | Times Cited: 20

S2k guideline: Diagnosis and therapy of localized scleroderma
Alexander Kreuter, Pia Moinzadeh, Maria Kinberger, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 4, pp. 605-620
Open Access | Times Cited: 2

Morbidity and Disability in Juvenile Localized Scleroderma: The Case for Early Recognition and Systemic Immunosuppressive Treatment
Suzanne C. Li, Kathleen M. O’Neil, Gloria C. Higgins
The Journal of Pediatrics (2021) Vol. 234, pp. 245-256.e2
Closed Access | Times Cited: 14

Recent Advances in Treatment of Systemic Sclerosis and Morphea
Noelle Teske, Nicole Fett
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 2, pp. 213-226
Closed Access | Times Cited: 5

Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments
Suzanne C. Li
Current Opinion in Rheumatology (2022) Vol. 34, Iss. 5, pp. 245-254
Closed Access | Times Cited: 7

S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie
Alexander Kreuter, Pia Moinzadeh, Maria Kinberger, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 4, pp. 605-621
Open Access | Times Cited: 1

Pediatric morphea state‐of‐the‐art literature review: Reframing morphea as a systemic disease
Jacquelyn R. Sink, Yvonne E. Chiu
Pediatric Dermatology (2021) Vol. 38, Iss. 5, pp. 1020-1031
Closed Access | Times Cited: 9

Diagnosis and management of morphoea in children: an overview
Lisa Weibel
Clinical and Experimental Dermatology (2021) Vol. 46, Iss. 3, pp. 487-494
Closed Access | Times Cited: 7

Non-invasive imaging and clinical skin scores in juvenile localized scleroderma
Clare Pain, Andrea Murray, Graham Dinsdale, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 5, pp. 1332-1340
Closed Access | Times Cited: 2

Systemic therapy in juvenile localized scleroderma
Ivan Foeldvari, Edoardo Marrani
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 10, pp. 1225-1238
Closed Access | Times Cited: 1

Evaluation and Treatment of Pediatric Localized Scleroderma: Pearls and Updates
Daniel Glaser, Kathryn S. Torok
Current Treatment Options in Rheumatology (2021) Vol. 7, Iss. 1, pp. 1-20
Closed Access | Times Cited: 3

Identification of lncRNA expression profiles in pediatric localized scleroderma
Yinv Gong, Haimei Liu, Guomin Li, et al.
Journal of Cosmetic Dermatology (2022) Vol. 21, Iss. 11, pp. 6422-6427
Closed Access | Times Cited: 2

Advances in autoimmune cutaneous diseases
Silvia Angélica Carmona‐Cruz, Maria Teresa García‐Romero
Elsevier eBooks (2022), pp. 333-371
Closed Access | Times Cited: 1

Excimer laser treatment for morphea-lichen sclerosus et atrophicus overlap in a pediatric patient
Emily Hong, Alba Posligua, Hillary Elwood, et al.
JAAD Case Reports (2022) Vol. 32, pp. 96-98
Open Access | Times Cited: 1

Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy
Sayuko Nagaoka, Shujiro Hayashi, Ken Igawa
Journal of Cutaneous Immunology and Allergy (2021) Vol. 5, Iss. 3, pp. 94-96
Open Access | Times Cited: 1

Problems of systemic connective tissue diseases of childhood in historical perspective
М. I. Kaleda, И. П. Никишина
Rheumatology Science and Practice (2023) Vol. 61, Iss. 6, pp. 639-649
Open Access

Page 1 - Next Page

Scroll to top